ProAssurance (PRA) Q4 2024 earnings summary

Executive summary

• Achieved fifth consecutive quarter of improved operating earnings, with Q4 2024 net income of $16.2M ($0.31/diluted share) and full-year net income of $52.7M ($1.03/diluted share); operating income for the year was $48.6M ($0.95/diluted share).

• Book value per share rose to $23.49 at year-end 2024, with non-GAAP adjusted book value per share at $26.86.

• Specialty P&C segment, mainly Medical Professional Liability, represents over 75% of total earned premium; renewal premium increases of 8–10% in Q4.

• Management continues to focus on profitability, disciplined underwriting, and selective growth in targeted healthcare market segments.

• Prioritizing profitability over growth, with disciplined rate increases and selective underwriting.

Financial highlights

• Full-year operating earnings reached $0.95 per share, with an operating ratio of 94.5%.

• Net investment income rose 9% for the quarter and 12.6% for the year, with new purchase yields at 5.8%.

• Book value per share increased by $1.67 to $23.49; adjusted book value per share at $26.86.

• Q4 2024 gross premiums written were $207.7M, down 0.5% year-over-year; full-year gross premiums written were $1.05B, down 2.9%.

• Q4 net income rose 153.6% year-over-year; full-year net income swung from a $38.6M loss in 2023 to $52.7M profit in 2024.

Outlook and guidance

• Expect continued focus on rate adequacy and underwriting discipline in 2025, with profitability prioritized over growth.

• Anticipate similar market conditions and competitive pressures in 2025 as in 2024.

• Workers' compensation strategy remains to keep rates flat despite industry-wide loss cost declines.

• Cautious optimism about cyclical insurance markets responding to pricing and underwriting discipline.